HBK Investments’s SpringWorks Therapeutics SWTX Stock Holding History

HBK Investments’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,608,340	Closed	-$123M	–	287
2025 Q2	$123M	Buy	+2,608,340	New	+$116M	1.6%	15

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

HBK Investments's SWTX Position: Q3 2025 in Review

HBK Investments sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 2,608,340 shares — an estimated $123M sold.

HBK Investments first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $123M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

HBK Investments reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
HBK Investments sold 2,608,340 SpringWorks Therapeutics shares in Q3 2025, an estimated $123M.
HBK Investments first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
HBK Investments's SpringWorks Therapeutics position peaked at $123M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on HBK Investments's 13F filing for Q3 2025, filed 14 Nov 2025.